Hepatocellular carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Willing to sign informed consent; 2. Aged 18 to 80 years, male or female; 3. No previous history of malignant tumor; 4. One of the following diseases: malignant solid tumor of digestive system: primary hepatocellular carcinoma (excluding mixed hepatobiliary carcinoma), metastatic hepatocellular carcinoma, cholangiocarcinoma, pancreatic cancer, gastric cancer, etc; Hepatic cavernous hemangioma and other benign tumors; Liver cirrhosis, chronic hepatitis B, chronic hepatitis C; 5. Tumor patients should be newly diagnosed and have not received any anti-tumor treatment, including but not limited to surgery, radiotherapy, chemotherapy, etc; 6. The relevant information of the sample is complete, including subject number, sample type, hospitalization number, age, gender, sample collection time, clinical diagnosis, etc; 7. The volume of blood sample shall not be less than 10ml.
Exclusion criteria
Exclusion criteria: 1. They did not meet the inclusion criteria; 2. Pregnant or lactating women; 3. The subjects received allogeneic blood transfusion or cell therapy within one year; 4. The subjects had received organ transplantation in the last 3 months; 5. There are two or more primary malignant tumors from different organs and tissues at the same time; 6. Anemia or severe blood loss in recent one month; 7. Failure to express personal wishes or mental illness may affect the compliance of the program; 8. The researcher thinks that it is not suitable to participate in this study; 9. Hemolysis occurred during blood sample collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cell-free DNA; | — |
Countries
China
Contacts
Hunan Provincial People's Hospital